Search

everythinglearnresearchcommunity

for

Search:↓

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

HMPV causes respiratory infections, mainly managed with supportive care, and lacks a vaccine or specific treatment.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

Beta-HPV and MCPyV are linked to certain skin cancers, with ongoing research and vaccine development.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Dupilumab and COVID-19 can worsen or trigger psoriasis.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Swellable microneedles could improve drug delivery and diagnostics but need more research on materials and technology integration.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Scalp involvement in primary cutaneous lymphomas is common and can be aggressive, requiring careful attention.

Liposomes with certain properties can effectively deliver drugs deep into hair follicles.

The document concludes that women's health needs a holistic approach, considering all life stages, promoting lifestyle changes, regular exercise, proper diet, and vaccinations, with health professionals playing a key role in education and guidance.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Various drugs caused different skin reactions, including allergic and inflammatory responses.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Higher free testosterone levels in men are linked to a stronger immune response, not weaker.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Dissolving microneedles offer efficient, minimally invasive drug delivery through the skin.